Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A K Tikhaze

Showing results (1-10 of 66) with videos related to

Pageof 7
Sort By:
Kardiologiia|March 15, 2017
[Free Radical Processes Play an Important Role in the Etiology and Pathogenesis of Atherosclerosis and Diabetes]V Z Lankin, A K Tikhaze
Biulleten' Eksperimental'Noi Biologii I Meditsiny|May 1, 1980
[Glutathione peroxidase II activity in the blood of hypercholesteremic mammals]V Z Lankin, A K Tikhaze
Doklady. Biochemistry and Biophysics|January 6, 2016
Fructose as an inducer of free radical peroxidation of natural lipid-protein supramolecular complexesV Z Lankin, G G Konovalova, A K Tikhaze
Biochemistry. Biokhimiia|June 13, 2002
Modeling the cascade of enzymatic reactions in liposomes including successive free radical peroxidation, reduction, and hydrolysis of phospholipid polyenoic acyls for studying the effect of these processes on the structural-dynamic parameters of the membranesV Z Lankin, A K Tikhaze, Yu G Osis
Bulletin of Experimental Biology and Medicine|January 5, 2001
Antioxidant activity of parapharmaceutics containing natural inhibitors of free radical processesG G Konovalova, A K Tikhaze, V Z Lankin
Kardiologiia|February 1, 1976
[Lipid peroxides and arteriosclerosis]V Z Lankin, A K Tikhaze, N V Kotelevtseva
Biomeditsinskaia Khimiia|December 29, 2020
[Elimination kinetics of carbonyl-modified low density lipoproteins from bloodstream]A K Tikhaze, S P Domogatsky, V Z Lankin
Kardiologiia|March 19, 2004
[Antioxidants in complex therapy of atherosclerosis: pro et contra]V Z Lankin, A K Tikhaze, Iu N Belenkov
Molecular and Cellular Biochemistry|February 7, 2012
Macrophages actively accumulate malonyldialdehyde-modified but not enzymatically oxidized low density lipoproteinV Z Lankin, A K Tikhaze, E M Kumskova
Terapevticheskii Arkhiv|February 1, 2019
PCSK9 Inhibitor causes a decrease in the level of oxidatively modified low-density lipoproteins in patients with coronary artery diseasesV Z Lankin, A K Tikhaze, M Viigimaa, et al.
Pageof 7

Showing results (1-10 of 66) with videos related to

Sort By:
Pageof 7
Kardiologiia|March 15, 2017
[Free Radical Processes Play an Important Role in the Etiology and Pathogenesis of Atherosclerosis and Diabetes]V Z Lankin, A K Tikhaze
Biulleten' Eksperimental'Noi Biologii I Meditsiny|May 1, 1980
[Glutathione peroxidase II activity in the blood of hypercholesteremic mammals]V Z Lankin, A K Tikhaze
Doklady. Biochemistry and Biophysics|January 6, 2016
Fructose as an inducer of free radical peroxidation of natural lipid-protein supramolecular complexesV Z Lankin, G G Konovalova, A K Tikhaze
Biochemistry. Biokhimiia|June 13, 2002
Modeling the cascade of enzymatic reactions in liposomes including successive free radical peroxidation, reduction, and hydrolysis of phospholipid polyenoic acyls for studying the effect of these processes on the structural-dynamic parameters of the membranesV Z Lankin, A K Tikhaze, Yu G Osis
Bulletin of Experimental Biology and Medicine|January 5, 2001
Antioxidant activity of parapharmaceutics containing natural inhibitors of free radical processesG G Konovalova, A K Tikhaze, V Z Lankin
Kardiologiia|February 1, 1976
[Lipid peroxides and arteriosclerosis]V Z Lankin, A K Tikhaze, N V Kotelevtseva
Biomeditsinskaia Khimiia|December 29, 2020
[Elimination kinetics of carbonyl-modified low density lipoproteins from bloodstream]A K Tikhaze, S P Domogatsky, V Z Lankin
Kardiologiia|March 19, 2004
[Antioxidants in complex therapy of atherosclerosis: pro et contra]V Z Lankin, A K Tikhaze, Iu N Belenkov
Molecular and Cellular Biochemistry|February 7, 2012
Macrophages actively accumulate malonyldialdehyde-modified but not enzymatically oxidized low density lipoproteinV Z Lankin, A K Tikhaze, E M Kumskova
Terapevticheskii Arkhiv|February 1, 2019
PCSK9 Inhibitor causes a decrease in the level of oxidatively modified low-density lipoproteins in patients with coronary artery diseasesV Z Lankin, A K Tikhaze, M Viigimaa, et al.
Pageof 7